Angiotensin-converting enzyme 2 (ACE2) and TMPRSS2 facilitate SARS-CoV-2 infection in cells, and the TMPRSS2 inhibitor has been proposed as a potential treatment for COVID-19. Here, ACE2 is linked to COVID-19.